Landscape of Statin as a Cornerstone in Atherosclerotic Cardiovascular Disease

被引:3
|
作者
Yang, Cheng [1 ]
Wu, Yong-Jian [1 ]
Qian, Jie [1 ]
Li, Jian-Jun [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100037, Peoples R China
关键词
statins; cardiovascular disease; lipid-lowering; cornerstone; CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN-CHOLESTEROL; ACUTE MYOCARDIAL-INFARCTION; LOWERING LDL CHOLESTEROL; RANDOMIZED CONTROLLED-TRIALS; CONSENSUS DECISION PATHWAY; CHRONIC KIDNEY-DISEASE; HIGH-DOSE ATORVASTATIN; PRIMARY PREVENTION; ISCHEMIC-STROKE;
D O I
10.31083/j.rcm2412373
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atherosclerosis, the key pathogenesis of cardiovascular disease, is a leading cause of death and disability worldwide. Statins are first-line lipid-lowering drugs, which have been demonstrated to be powerful agents for anti-atherosclerosis. Numerous studies have confirmed the cardiovascular benefits and long-term safety of statins in a wide range of patients. Statins play an indispensable and irreplaceable part in the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD). In this article, we summarize the evolution of statins and their role in the treatment of cholesterol. The anti-atherosclerotic mechanism of statins, its efficacy, safety and clinical outcomes in secondary and primary prevention of ACSVD in different patient populations, the combination treatment effects, and guideline recommendations are also detailed. This paper highlights the profound significance of statins as the most successful anti-atherogenic drug in the cardiovascular field.
引用
收藏
页数:22
相关论文
共 50 条
  • [21] Low statin use in nondialysis-dependent chronic kidney disease in the absence of clinical atherosclerotic cardiovascular disease or diabetes
    Markossian, Talar W.
    Kramer, Holly J.
    Burge, Nicholas J.
    Pacold, Ivan V.
    Leehey, David J.
    Huo, Zhiping
    Schneider, Julia
    Ling, Benjamin
    Stroupe, Kevin T.
    CLINICAL KIDNEY JOURNAL, 2019, 12 (04) : 530 - 537
  • [22] Impact of incident diabetes on atherosclerotic cardiovascular disease according to statin use history among postmenopausal women
    Ma, Yunsheng
    Persuitte, Gioia M.
    Andrews, Christopher
    Hovey, Kathleen M.
    LaMonte, Michael J.
    Culver, Annie L.
    Manson, JoAnn E.
    Phillips, Lawrence S.
    Liu, Simin
    Eaton, Charles
    Martin, Lisa W.
    Howard, Barbara V.
    Balasubramanian, Raji
    Bird, Chloe E.
    Ockene, Ira S.
    Sturgeon, Susan R.
    Ockene, Judith K.
    Tinker, Lesley
    Nassir, Rami
    Rossouw, Jacques
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2016, 31 (08) : 747 - 761
  • [23] Dietary modulators of statin efficacy in cardiovascular disease and cognition
    Wang, Huifen
    Blumberg, Jeffrey B.
    Chen, C. -Y. Oliver
    Choi, Sang-Woon
    Corcoran, Michael P.
    Harris, Susan S.
    Jacques, Paul F.
    Kristo, Aleksandra S.
    Lai, Chao-Qiang
    Lamon-Fava, Stefania
    Matthan, Nirupa R.
    McKay, Diane L.
    Meydani, Mohsen
    Parnell, Laurence D.
    Prokopy, Max P.
    Scott, Tammy M.
    Lichtenstein, Alice H.
    MOLECULAR ASPECTS OF MEDICINE, 2014, 38 : 1 - 53
  • [24] Stress and Atherosclerotic Cardiovascular Disease
    Inoue, Nobutaka
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2014, 21 (05) : 391 - 401
  • [25] Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk
    Yanai, Hidekatsu
    Adachi, Hiroki
    Hakoshima, Mariko
    Katsuyama, Hisayuki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [26] Cardiovascular Genetic Risk Testing for Targeting Statin Therapy in the Primary Prevention of Atherosclerotic Cardiovascular Disease A Cost-Effectiveness Analysis
    Jarmul, Jamie
    Pletcher, Mark J.
    Lich, Kristen Hassmiller
    Wheeler, Stephanie B.
    Weinberger, Morris
    Avery, Christy L.
    Jonas, Daniel E.
    Earnshaw, Stephanie
    Pignone, Michael
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2018, 11 (04):
  • [27] Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease
    Erqou, Sebhat
    Papaila, Alexa
    Halladay, Christopher
    Ge, Augustus
    Liu, Michael A.
    Jiang, Lan
    Lally, Michelle
    Menon, Anupama
    Shah, Nishant R.
    Miech, Edward
    Virani, Salim S.
    Zullo, Andrew R.
    Shireman, Theresa, I
    Longenecker, Christopher T.
    Ross, David
    Sullivan, Jennifer L.
    Wu, Wen-Chih
    Rudolph, James L.
    AMERICAN HEART JOURNAL, 2022, 249 : 12 - 22
  • [28] Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition
    Rosenblit, Paul D.
    CURRENT DIABETES REPORTS, 2019, 19 (08)
  • [29] Atherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy
    Kaplan-Lewis, Emma
    Aberg, Judith A.
    Lee, Mikyung
    CURRENT HIV/AIDS REPORTS, 2016, 13 (05) : 297 - 308
  • [30] Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease
    Mahtta, Dhruv
    Ramsey, David J.
    Al Rifai, Mahmoud
    Nasir, Khurram
    Samad, Zainab
    Aguilar, David
    Jneid, Hani
    Ballantyne, Christie M.
    Petersen, Laura A.
    Virani, Salim S.
    JAMA NETWORK OPEN, 2020, 3 (08)